|
| Exchange Received Time 02/12/2019 11:01:23 Exchange Disseminated Time 02/12/2019 11:01:31 Time Taken 00:00:08 | With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Tentative Approval for Diclofenac Sodium Topical Solution USP, 2% w/w.
Please find enclosed herewith our press release.
We request you to kindly take the same on record.
|
|
|